Skip to content
1887
Volume 52, Issue 3
  • ISSN: 0032-1400

Abstract

A series of novel lipophilic platinum(II) compounds containing salicylate derivatives as the leaving group have been designed, synthesised and characterised. Most of the platinum compounds exhibit high solubility and have a partition coefficient suited to liposomal encapsulation. Some of the compounds are more pharmacologically active and/or less toxic than carboplatin and oxaliplatin. The liposomal formulation of the most promising compound has been successfully prepared with long stability and high encapsulation rate, showing great potential to be developed as a new tumour-target drug.

Loading

Article metrics loading...

/content/journals/10.1595/147106708X324845
2008-07-31
2024-02-26
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.1595/147106708X324845
Loading
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error